MAP4K4 Inhibition Promotes Survival of Human Stem Cell-Derived Cardiomyocytes and Reduces Infarct Size In Vivo

Cell Stem Cell. 2020 Mar 5;26(3):458. doi: 10.1016/j.stem.2020.01.015.
No abstract available

Publication types

  • Published Erratum